Search

Your search keyword '"Harvey W. Kaufman"' showing total 71 results

Search Constraints

Start Over You searched for: Author "Harvey W. Kaufman" Remove constraint Author: "Harvey W. Kaufman" Topic medicine Remove constraint Topic: medicine
Sorry, I don't understand your search. ×
71 results on '"Harvey W. Kaufman"'

Search Results

1. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels

2. Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010 to 2018

Catalog

Books, media, physical & digital resources

3. Associations of aerobic and strength exercise with clinical laboratory test values.

4. Notes from the Field: Testing for Nonprescribed Fentanyl and Percentage of Positive Test Results Among Patients with Opioid Use Disorder — United States, 2019–2020

5. Chlamydia and Gonorrhea: Shifting Age-Based Positivity Among Young Females, 2010–2017

6. Geographic regions with high prevalence of nonalcoholic steatohepatitis-related hepatic fibrosis are also observed to demonstrate high prevalence of metabolic disease risk factors and low consumption of fruits and vegetables

7. Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic

8. Temporal relationship between vitamin D status and parathyroid hormone in the United States.

9. Changes in Newly Identified Cancer Among US Patients From Before COVID-19 Through the First Full Year of the Pandemic

10. Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL

11. Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States

12. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017

13. Drug Misuse and Hepatitis C Virus Infection Profiles for Three Generations of Patients Being Monitored for Prescription Drug Adherence

14. Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic

15. Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Screening in the U.S

16. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

17. Disparities in SARS-CoV-2 Positivity Rates: Associations with Race and Ethnicity

18. Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March–July 2020

19. Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening

20. Blood cholesterol trends 2001-2011 in the United States: analysis of 105 million patient records.

21. Cotesting in Cervical Cancer Screening

22. Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection

23. Shorter drug testing intervals are associated with improved drug misuse rates

24. Association of ABO / Rh with SARS‐CoV‐2 positivity: The role of race and ethnicity in a female cohort

25. Pooling of Upper Respiratory Specimens Using a SARS-CoV-2 Real Time RT-PCR Assay Authorized for Emergency Use in Low Prevalence Populations for High-Throughput Testing

26. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

27. Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States

28. Q fever: an under-reported reportable communicable disease

29. Value of laboratory tests in employer-sponsored health risk assessments for newly identifying health conditions: analysis of 52,270 participants.

30. Individual- and Community-Level Factors Associated With Detectable and Elevated Blood Lead Levels in US Children

32. Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory

33. Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States

34. Laboratory Blood-Based Testing for Non-Lyme Disease Tick-Borne Infections at a National Reference Laboratory

35. Laboratory Blood-Based Testing for Lyme Disease at a National Reference Laboratory

36. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020

37. Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women’s Health Study

38. Vitamin D Status and Supplementation in Employer-Sponsored Wellness Program

39. Hepatitis A surveillance using commercial laboratory data

41. Triangulating Dynamic of Clinical Laboratory Testing

42. Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children

43. Revised prevalence estimate of possible Hereditary Xerocytosis as derived from a large U.S. Laboratory database

44. Associations of aerobic and strength exercise with clinical laboratory test values

45. National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

46. Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis

48. Reply

49. Blood Lead Levels in Young Children: US, 2009-2015

50. National Status of Testing for Hypothyroidism during Pregnancy and Postpartum